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Impact of splenic artery ligation 
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Dulce Cardoso8, Ana Bela Sarmento-Ribeiro4,5,7,9, Clara Rocha10,11, Jorge Nunes Santos2, 
Maria Filomena Botelho3,4,5, José Guilherme Tralhão3,4,5,12, Olivier Farges13 & 
Jorge Maciel Barbosa1,14
It was reported that prevention of acute portal overpressure in small-for-size livers by inflow modulation 
results in a better postoperative outcome. The aim is to investigate the impact of portal blood flow 
reduction by splenic artery ligation after major hepatectomy in a murine model. Forty-eight rats 
were subjected to an 85% hepatectomy or 85% hepatectomy and splenic artery ligation. Both groups 
were evaluated at 24, 48, 72 and 120 post-operative hours: liver function, regeneration and viability. 
All methods and experiments were carried out in accordance with Coimbra University guidelines. 
Splenic artery ligation produces viability increase after 24 h, induces a relative decrease in oxidative 
stress during the first 48 hours, allows antioxidant capacity increment after 24 h, which is reflected in 
a decrease of half-time normalized liver curve at 48 h and at 72 h and in an increase of mitotic index 
between 48 h and 72 h. Splenic artery ligation combined with 85% hepatectomy in a murine model, 
allows portal inflow modulation, promoting an increase in hepatocellular viability and regeneration, 
without impairing the function, probably by inducing a less marked elevation of oxidative stress at first 
48 hours.
Major hepatectomy (MH), traditionally defined as the resection of 3 or more segments, is currently the standard 
treatment for liver benign or malignant diseases, allowing also collecting grafts in living donor liver transplanta-
tion (LDLT)1.
Several factors have been implicated in the increasing survival rate of patients undergoing major hepatectomy, 
as it has been shown in the last 15 years1–3. Examples of this are: implementation of multidisciplinary oncosurgi-
cal strategies, greater efficacy of chemotherapeutic drugs, whole range of instrumentation and techniques used 
in perioperative period, better accuracy in selection of candidates for hepatectomy/transplantation through a 
rigorous evaluation of preoperative liver function4–6 and more precise estimation of future liver remnant (FLR), 
besides its increment through selective portal embolization or iterative hepatectomy7,8.
Despite technical advancement, posthepatectomy mortality remains a concern, being the main cause of liver 
failure1,7. In fact, the greatest limitation of liver neoplasms therapeutic strategy is currently the percentage of 
remaining functional liver after hepatectomy. In other words, the pivotal point of recovery after MH is liver 
regeneration2.
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Several reports suggest that postoperative liver failure is due to reduced liver volume and posthepatectomy 
hemodynamic changes, that induce production of reactive oxygen species (ROS) and inflammatory cytokines, 
leading to hepatic necrosis and apoptosis1,2,9,10. Although adequate portal venous flow and pressure may play a 
very important role in liver regeneration, these rapid hemodynamic changes can lead to excessive portal flow to 
residual liver, which may cause high portal pressure, and consequent sinusoidal injury, hepatic parenchymal dam-
ages and residual liver hypertrophy accompanied by liver dysfunction2,10. Similar development has been detected 
in adult LDLT, presumably due to size mismatch between graft and recipient9.
With the increasing of LDLT practice and resection of larger tumours, the “small-for-size” syndrome 
(SFSS) has emerged as an important clinical problem2,9,10. More recently, it has been proposed the concept of 
“small-for-flow” based on the assumption that posthepatectomy liver failure (PHLF) and SFSS in LDLT would 
have the same origin, related to excessive portal flow for residual hepatic parenchyma, generating a sinusoidal 
overpressure, capillary denudation and bleeding9.
Different studies have shown the importance of portal venous pressure (PVP) in the development of liver 
failure after MH or LDLT, in patients with previous liver damage10–12 or in non-cirrhotic livers1, focusing the 
importance of PVP early evaluation after hepatectomy as an independent predictor of liver failure developing 
after MH9,13. Considering the pathophysiology of endothelial injury generated by portal overpressure, several 
strategies have been proposed to modulate portal inflow. In this context, pharmacological trials and surgical 
techniques have been tested, not only individually but as a complement, namely somatostatin and analogues14–16, 
prostaglandin E117,18, FK 409 and FTY 72019,20, terlipressin21, inhalation of nitric oxide, carbon monoxide and 
hydrogen22–24, portal caval shunt25,26 or other portal derivative manoeuvres to prevent its excessive shunting and 
frequent complications27,28, plasmapheresis and other plasma purification procedures in order to decrease serum 
toxin levels29,30.
However, none of these strategies resulted in a significant survival increase because they have shown an inhib-
itory effect on liver regeneration after hepatectomy, which limits their use in hepatic surgery31. Simultaneously, 
they have revealed, in animal models, significant morbidity and mortality or they simply do not act in the patho-
genic mechanism responsible for these syndromes – portal venous overpressure29.
Assuming the splenic blood flow fraction up to 52% of the total portal inflow, its contribution to portal over-
pressure is evident32. Therefore, effects of splenectomy after major hepatectomy have also been investigated32,33. 
However, the immunological effect of splenectomy and the incidence of septic complications are still contro-
versial34–36. In order to induce less iatrogeny and reduce complications due to splenectomy, tests to evaluate the 
effects of portal inflow prophylactic modulation through the splenic artery ligation were performed37,38. These 
results have been promising, despite confining themselves to case reports or small cohort studies. In a more 
experimental manner, Ito et al. and Irie et al. studied the effects of splenic artery ligation in rats submitted to 
major hepatectomy39,40. However, additionally to splenic artery ligation, both included a procedure that induces 
ischemic/reperfusion injury, which is a bias. Furthermore, the first work confines itself to study the injurious 
effects on liver parenchyma, cell regeneration and survival, while the second one specifically tested the protective 
effect of the splenic artery ligation through induction of heme oxygenase-1 (HO-1) expression.
For these reasons we propose to perform a wider research on the impact of splenic artery ligation, as a tech-
nically feasible manoeuver to modulate the portal inflow after major hepatectomy in a murine model, assessing 
their effects on hepatocellular function, regeneration and viability. We chose this model because it is the animal 
model which is the long used concerning hepatocellular regeneration research41, of easy manipulation and whose 
size allows performing radioisotopic evaluations. Additionally, it is a model in which we have great experience.
Results
Mortality. The results demonstrated that there was no mortality in a control group of 10 animals subjected to 
85% hepatectomy (Hx) with (5 rats) or without ligation of the splenic artery (Hx + Asp) (5 rats), on the seventh 
postoperative day.
Hepatic extraction fraction (HEF), time of maximum liver activity (Tmax) and half-time of nor-
malized liver curve (T1/2) evaluation by radioisotopic methods. The hepatic extraction fraction 
(HEF) evaluation after 99mTc-mebofrenin injection allows the study of hepatocyte radiopharmaceutical uptake 
and excretion kinetics. Therefore, after image processing are obtained different parameters: the time of maxi-
mum liver activity uptake (Tmax), the half-time of the normalized liver elimination curve (T1/2) and the hepatic 
extraction fraction (HEF). All these data are able to give accurate information about the dynamic function of the 
hepatocytes after radiopharmaceutical uptake5.
When the HEF was evaluated, there were no differences over time, as shown in Fig. 1, when an 85% hepa-
tectomy was performed. Identical results were obtained when splenic artery ligation was carried out (Fig. 1a). 
This surgical manoeuver induced an increase on Tmax at first 24 h, which became irrelevant in subsequent times 
(p < 0.001). However there were no differences between Hx and Hx + Asp groups at 48 hours (Fig. 1b). In addi-
tion, for both groups, splenic artery ligation induced a decrease of T1/2 at 48 h (p < 0.001) and at 72 h (p = 0.052), 
with a recovery of this condition at 120 h (Fig. 1c).
Cell viability. In order to evaluate the impact of Hx and Hx + Asp in remnant liver cells, cell viability was 
assessed by flow cytometry through annexin V/propidium iodide double staining (Fig. 2). As shown in Fig. 2a, 
there were no significant differences on living cells over time, among Hx + Asp sub-groups. However, when we 
compared the Hx sub-groups, there was a significant gradual decrease (p < 0.001) over time.
In both groups, there was an increase of initial apoptotic cells (Fig. 2b) at 48 hours (p < 0.001) which decreased 
over time. However, these changes were more pronounced in sub-groups submitted to splenic artery ligation 
(p < 0.01 for 48 h–72 h Hx group versus p < 0.001 for 48 h–72 h Hx + Asp group).
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As observed in Fig. 2c, at 72 h there was an increase of late apoptosis/necrosis cells in both groups, most prom-
inent in group not submitted to splenic artery ligation (p < 0.001 for Hx group versus p = 0.004 for Hx + Asp 
group). At 120 h this trend keeps away without statistically significant differences between the groups.
In relation to necrotic cells, there was an increase at 120 h on the Hx group compared with previous times 
(p < 0.001). On the Hx + Asp group no differences were noticed over time (Fig. 2d).
Comparing Hx with Hx + Asp groups there was a progressive increase of living cells in the group submitted 
to splenic artery ligation (p < 0.001) (Fig. 2a), an increase of initial apoptosis cells at 24 h more marked on Hx 
Figure 1. Radioisotopic results. (a) Hepatic extraction fraction (HEF) evaluation by radioisotopic methods. 
(b) Time of maximum liver activity (Tmax). (c) Half-time of the normalized liver curve. HEF results are 
expressed as average of percentage and the others are expressed in average of minutes ± standard deviation, 
from six rats in each group. ***p < 0.001; **p < 0.01; *p < 0.05.
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group (p < 0.01) (Fig. 2b), and also an increase of late apoptosis/necrosis cells at 72 h (p < 0.001) (Fig. 2c). It was 
observed a gradual increase of necrotic cells on the Hx group over time, which became more expressive at 120 h 
(p < 0.001) (Fig. 2d).
Oxidative Stress. As mentioned before, postoperative liver failure may be related with ROS production. In 
this context, we analysed intracellular levels of ROS, peroxides and superoxide anion, and GSH (a non-enzymatic 
antioxidant defence). When we analysed the ROS accumulation (Fig. 3a), at 24 h there was a significant increase 
of intracellular peroxide production in both groups (p < 0.05), more expressive in the group without splenic 
artery ligation (p < 0.001). This difference between the two groups remained significant (p < 0.05) at 48 h and at 
120 h.
Concerning the results obtained for intracellular accumulation of superoxide radical (Fig. 3b), there was an 
increase at 48 h in both groups, most prominent in the group not submitted to splenic artery ligation (p < 0.001). 
At 120 h this difference between Hx and Hx + Asp groups remained significant (p < 0.05).
In order to better characterize the effect of splenic artery ligation after hepatectomy on cellular oxidative 
stress, it was also measured the reduced glutathione (GSH) anti-oxidant capacity. As shown in Fig. 4, there was 
an increase of anti-oxidant capacity at 24 h in both groups (p < 0.001), more expressive in the group submit-
ted to splenic artery ligation (p < 0.05). This procedure induced, over time, a decrease of anti-oxidant capacity 
(p < 0.05).
Mitochondrial membrane potential estimation. Mitochondrial signalling regulates the communica-
tion between mitochondria and nucleus influencing many cellular responses under normal or pathophysiological 
conditions42. In this context, we analysed the mitochondrial membrane potential by flow cytometry using the 
fluorescent probe JC-1. As shown in Fig. 5, at 120 h there was a significant decrease of mitochondrial membrane 
Figure 2. Evaluation of cellular viability and death by flow cytometry. (a) Live cells. (b) Initial apoptosis.  
(c) Late apoptosis/necrosis. (d) Necrosis. Hepatocytes were extracted at 24, 48, 72 and 120 postoperative hours, 
from rats submitted to hepatectomy (Hx) or hepatectomy + splenic artery ligation (Hx + Asp). Cell death was 
detected by annexin V and propidium iodide staining and analysed by flow cytometry. Results are expressed 
as average of percentage of each type of cells ± standard deviation obtained from six rats in each group. 
***p < 0.001; **p < 0.01; *p < 0.05. — Baseline value in a control group without any procedure.
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Figure 3. Oxidative stress evaluation. (a) Intracellular peroxides. (b) Intracellular superoxide. The peroxide 
and superoxide levels were analysed by flow cytometry using the DCFH2-DA and dihydroethidium (DHE) 
fluorescent probes. Hepatocytes were extracted at 24, 48, 72 and 120 postoperative hours, from rats submitted 
to hepatectomy (Hx) or hepatectomy + splenic artery ligation (Hx + Asp). Results are expressed as MFI 
values ± standard deviation in hepatocytes extracted from six rats in each group. ***p < 0.001; **p < 0.01; 
*p < 0.05. — Baseline value in a control group without any procedure.
Figure 4. Antioxidant capacity performed by flow cytometry using mercury orange as fluorescent 
compound. Hepatocytes were extracted at 24, 48, 72 and 120 postoperative hours, from rats submitted to 
hepatectomy (Hx) or hepatectomy + splenic artery ligation (Hx + Asp). Results are expressed by MFI values 
of GSH expression ± standard deviation, in hepatocytes extracted from six rats in each group. ***p < 0.001; 
**p < 0.01; *p < 0.05. — Baseline value in a control group without any procedure.
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potential in both groups, expressed by monomers-aggregates ratio (M/A) of JC-1 increase, comparing with 
48 hours (p < 0.05), being more expressive in the group submitted to splenic artery ligation (p < 0.05).
Histological analysis - Tissue injury and hepatocyte regeneration. Concerning tissue injury, as 
shown in Fig. 6, in the Hx group there was an increase of hepatocyte ballooning percentage at 48 h, by comparison 
with the Hx + Asp group, which became gradually less expressive, but without statistical significance (Fig. 6a). 
In relation to microvesicular steatosis, there was a decrease in both groupsat 120 h, comparing to previous times 
(p < 0.05) (Fig. 6b). Regarding the percentage of neutrophil aggregates and the estimated hepatocyte necrosis/
apoptosis, there were no statistically differences among groups or over time (Fig. 6c,d). In Fig. 7 we can see the 
results of hepatocyte regeneration. They show an increase of mitotic index between 48 h and 72 h, more expressive 
in Hx + Asp groups (p < 0.05) (Fig. 7a). There was a tendency to the increment of Ki-67 expression between 48 h 
and 72 h, in both groups, most notoriously in Hx + Asp group, although without statistical significance (Fig. 7b). 
In supplementary material are shown all histological examples.
Discussion
The results of this study showed that splenic artery ligation produced significant viability increase at 24 h which 
remained over time, inducing a decrease in intracellular accumulation of peroxides and superoxide radical during 
the first 48 hours. This surgical approach also allowed antioxidant capacity increment at 24 h, which was reflected 
in a decrease of half-time normalized liver curve at 48 h and at 72 h and in an increase of mitotic index between 
the 48 h and 72 h.
Several experimental studies that include pharmacological therapies18–21,24 and surgical strategies25,32,39 to 
modulate portal influx corroborate these findings, demonstrating a mitigating effect on oxidative stress and an 
increase of hepatocyte viability. Despite splenic artery ligation did not have effects on hepatic extraction fraction 
and have generated a Tmax increase in the first 24 h, it induced a significant decrease of T1/2 at 48 h and 72 h for 
a significance level exceeding 5% (p = 0.052). This slight increase in hepatic depuration can be explained by the 
need for a longer period than 5 postoperative days to recover the hepatic function. Our previous research work 
supports this explanation5. Regarding histological analysis of hepatocytes, the splenic artery ligation, when asso-
ciated with a major hepatectomy, did not entail higher hepatocyte injury. In contrast and although there was no 
statistical significance, it seems that the modulation of portal inflow tends to protect the remaining liver paren-
chyma from the injury induced by hepatectomy, which is supported by previous studies which demonstrate atten-
uation of parenchymal injury following major hepatectomy, through portal inflow modulation9,25. The mitotic 
index increased in both groups, between 48 and 72 h, but more significantly in the group where splenic artery 
ligation was performed (p < 0.05), showing that this surgical manoeuver, by portal inflow modulation, induces 
a positive effect on cell regeneration, as it has been shown in previous works39,40. The tendency to increase Ki-67 
expression observed between 48 and 72 h, stronger in the Hx + Asp group, corroborates these results. However, 
the lack of statistical significance, in our opinion, can be due to the small sample in this variable.
The increased viability and regeneration in Hx + Asp group is probably a consequence of oxidative stress 
reduction at first 48 h and is caused by anti-oxidative capacity increment at the first 24 hours. Despite free rad-
ical generation during physiologic and pathologic conditions, cells had an arsenal of cellular defenses includ-
ing enzymatic defenses, such as superoxide dismutases (SODs), catalase, GSH peroxides, glutaredoxins, and 
Figure 5. Analysis of mitochondrial membrane potential by flow cytometry using fluorescent probe JC-1. 
Hepatocytes were extracted at 24, 48, 72 and 120 postoperative hours, from rats submitted to hepatectomy (Hx) 
or hepatectomy + splenic artery ligation (Hx + Asp). Then, they were isolated and stained with the JC-1 probe. 
JC-1 probe coexist in monomeric (M) or aggregated (A) form depending on the mitochondrial membrane 
potential. An increase in the M/A ratio indicates a decrease in the mitochondrial membrane potential. Results 
are expressed as average of monomers/aggregates ratio ± standard deviation, in hepatocytes extracted from 
six rats in each group. ***p < 0.001; **p < 0.01; *p < 0.05. — Baseline value in a control group without any 
procedure.
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non-enzymatic antioxidants, such as GSH, and vitamins A, C and E. The removal of ROS is efficiently ensured 
by the coordinated action of these cellular defenses. SODs catalyze the dismutation of superoxide anion into 
hydrogen peroxide43. During the first 24 h posthepatectomy, the SOD activity may be increased which caused the 
observed increase in intracellular peroxides levels in consequence of superoxide anion dismutation. However, after 
this time SOD activity may decline, inducing the increase in superoxide anion levels observed at 48 h posthepa-
tectomy and a subsequently decrease in hydrogen peroxide levels. Since we only analysed the intracellular levels 
of GSH the delay in superoxide formation needs to be further addressed in future studies, namely through SODs 
activity. Major hepatectomy had been associated with a transitory elevation in GSH levels44. Here, we observed 
that Hx and Hx + Asp induced an increase in GSH levels during the first 48 h after surgery relatively to normal 
levels (GSH 24 ± 6 MFI; data not shown), deceasing to normal values after 120 h. According to Huang et al., 
cellular GSH increases in regenerating rat liver during the first 24 h or 48 h44. This increase in GSH levels may 
reflect the shifting of cells from G0 to G1 phase or the G1 to S transition44, and can explain the higher cell viability, 
as well as the increased mitotic and Ki-67 indexes, observed in Hx + Asp in comparison to Hx.
Mitochondrial signaling regulates the communication between mitochondria and nucleus influencing many 
cellular responses under both normal and pathophysiological conditions42. During substrate oxidation, mito-
chondria produce a membrane potential in form of a proton gradient across mitochondrial inner membrane. 
Several factors can influence mitochondrial membrane potential, including apoptosis, external concentration of 
growth factors and glucose levels45. In the present study, we observed that Hx and Hx + Asp induced an increase 
in mitochondrial potential (represented by a decrease in monomers/aggregates ratio) in the first 48 h compar-
ing with the group at surgical time (3.78 ± 1.47; data not shown) that decrease at 120 h. In association with the 
increase in mitotic index and Ki-67 levels, this result may be associated with an increased proliferation. However, 
120 h after HX + Asp, it was observed a decrease in mitochondrial membrane potential not associated with cell 
death. This fact may be due to others factors also associated with a decline in mitochondrial membrane such as a 
decrease in growth factors levels.
Figure 6. Histological analysis of tissue injury. Sample of liver tissue collected at 24, 48, 72 and 120 
postoperative hours, from rats submitted to hepatectomy (Hx) or hepatectomy + splenic artery ligation 
(Hx + Asp). Results are expressed as median of the percentage for each tissue injury marker: hepatocyte 
ballooning (a), microvesicular steatosis (b), neutrophil aggregation (c) and estimation of hepatocyte necrosis/
apoptosis (d). Liver samples were collected from six rats in each group.
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The biomolecular findings evidenced in this paper, in line with previous experimental investigations about 
portal inflow modulation9,18–21,24,25,29,32,39,40, support the improved survival and decreased morbidity observed in 
previous clinical studies researching portal inflow modulation33,38.
In fact, portal inflow modulation may change future hepatic resection surgery and liver transplantation2,5,9. 
Nowadays, it could allow operate patients whose hepatic lesion and dysfunction, conditioned by their previous 
pathology or by neoadjuvant therapy, currently preclude them from major liver resections. In addition, it could 
allow the use of smaller liver grafts, without increased risk for SFSS, which determines lesser iatrogeny for the 
donor and makes possible the increase of compatible donor’s pool. Besides, it may also increase resection rate in 
metastatic disease, by allowing lower FLR minimum needed to avoid PHLF. Perform portal inflow modulation, 
through the splenic artery ligation, allows minimize the deleterious effects of portal venous overpressure and pre-
vent the SFSS, using a reproducible procedure, without compromising hepatocellular function, as we demonstrate 
in this work. It also opens doors to, in a future clinical approach, evaluate its effects on morbidity and survival of 
patients undergoing MH or LDLT.
In summary, this study shows that the splenic artery ligation combined to 85% hepatectomy in a murine 
model, allows portal inflow modulation, promoting an increase in hepatocellular viability and regeneration, with-
out impairing hepatic function, probably by inducing a less marked elevation of oxidative stress at first 48 hours 
after major hepatectomy.
Material and Methods
All methods and experiments were carried out in accordance with Coimbra University guidelines. Animals were 
housed and kept in accordance with the Institution of Animal Care of the University of Coimbra. All experiments 
protocols were carried out after approval by Faculty of Medicine of Coimbra Ethical Committee (ProcNumb 116-2011).
Figure 7. Histological analysis of hepatocyte regeneration. Samples of liver tissue collected at 24, 48, 72 and 
120 postoperative hours, from rats submitted to hepatectomy (Hx) or hepatectomy + splenic artery ligation 
(Hx + Asp). Mitotic activity (a) is expressed by average of mitosis counting in 10 consecutive fields of high 
magnification ± standard deviation, in liver samples collected from at least five rats in each group. Ki-67 (b) is 
expressed by average of percentage of positive hepatocellular nuclei/1000 hepatocytes ± standard deviation, in liver 
samples collected from six rats in each group. Exception: to observe Ki-67 expression were used 4 rats in each group.
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Animals. Eight-weeks-old male Wistar rats weighing between 200 and 300 g, were used. Animals were fed a 
laboratory diet with water and food ad libitum until surgery and were kept under constant environment condi-
tions with 12-hour light-dark cycle.
Forty-eight rats divided into two groups underwent 85% hepatectomy (Hx group n = 24) or 85% hepatectomy 
plus splenic artery ligation (Hx + Asp group, n = 24). Each group was divided into four sub-groups according to 
time of postoperative evaluation set at 24 (n = 6), 48 (n = 6), 72 (n = 6) and 120 (n = 6) postoperative hours. A 
control group of 10 animals were sacrificed on the 7th postoperative day.
Operative procedures. All animals were anesthetized with ethoxyethane by inhalation. Abdomen was 
opened through a midline incision and liver was freed of its ligaments. 85% hepatectomy with removal of the 
left lateral and median lobes were performed in all animals. Splenic artery ligation was performed on a control 
group (50%). Under our surgical conditions, a few branches of splenic artery were intact5,40,46,47. In each time after 
surgery (24, 48, 72 and 120 h) several variables were evaluated, using different techniques such as: flow cytometry 
to assess cell viability, oxidative stress levels, antioxidant capacity and mitochondria membrane potential; histo-
pathologic analysis to evaluate hepatic tissue damage and histological regeneration (mitotic index and Ki-67) and 
nuclear medicine evaluation in order to estimate hepatic extraction function.
Hepatic extraction fraction (HEF) evaluation by radioisotopic methods. For the HEF calcula-
tion, an IDA derivative, 3-bromo-2,4,6-trimethylacetanilidoiminodiacetic acid labelled with technetium-99 m 
(99 mTc-mebofrenin) was used. The labelling procedure was performed as recommended by the manufacturer5,13.
With the total counts from the ROIs drawn over heart and liver, time-activity curves were generated and HEF 
calculated by deconvolution analysis. Additionally, the Tmax and half-time of normalized liver curve (T1/2) were 
calculated, according to data processing described by Tralhão et al.13.
Liver cell isolation. Liver cells were isolated from liver fragments collected after animal sacrifice by using 
collagenase (Collagenase-Hepatocyte-Qualified – Gibco/BRL) as described elsewhere48. After liver cell isolation, 
viability and death, oxidative stress and mitochondrial membrane potential were evaluated by flow cytome-
try. Flow cytometry analysis was performed using a six-parameter, four-color FACS CaliburTM flow cytometer 
(Becton Dickinson) equipped with a 15 mW argon laser. For each assay 106 cells were used and at least 104 events 
were collected by acquisition using Cell Quest software (Becton Dickinson) and analysed using Paint-a-gate 
software (Becton Dickinson)13,49–51.
Cell death and viability analysis. Isolated hepatocytes were stained simultaneously with Annexin-V (AV), 
labelled with the fluorescent probe, fluorescein isothyocianate (FITC), and propidium iodide (PI), according to 
manufacturer’s recommended protocol (Immunotech Kit). This assay discriminates among intact (AV− /PI− ), 
early apoptotic (AV+ /PI− ), late apoptotic (AV+ /PI+ ) and necrotic cells (AV− /PI+ ). The results are shown as 
percentage of each cell type, as it was previously described by Mamede et al.13,51.
Oxidative Stress. The ROS accumulation in hepatocytes, namely peroxides, was evaluated using 2′ ,7′ 
-dichlorodihydrofluorescein diacetate (DCFH2-DA) (InvitrogenTM), a stable no fluorescent lipid permeable 
compound which is converted into DCFH2 by intracellular esterases. Then, DCFH2 is oxidized by intracellular 
ROS to form the impermeable fluorescent compound DCF that emits green fluorescence, after light excitation of 
488 nm, proportionally to intracellular ROS levels13,51,52.
Preparation protocol for DCF detection in hepatocytes was performed as previously described. The results are 
shown as mean fluorescence intensity (MFI) values13,50.
Assessment of intracellular superoxide radical production was performed by flow cytometry using dihydro-
ethidium (DHE). This compound readily crosses cellular membranes and is converted by the superoxide radical 
into ethidium, a red fluorescent compound that merges DNA and remaining inside the cell. This reaction is rela-
tively specific for superoxide radical with minimal oxidation by hydrogen peroxide, hypochlorous acid or nitrite. 
Ethidium detection protocol was performed with an excitation wavelength of 620 nm, according to described by 
Mamede et al. Results are shown as MFI values51,52.
Reduced glutathione (GSH) is the major endogenous antioxidant, directly participating in neutralization of 
free radicals and reactive oxygen species. Its intracellular concentration is proportional to the estimated antiox-
idant capacity of the cell. The GSH expression was performed by flow cytometry using as fluorescent compound 
the mercury orange, with an excitation wavelength of 620 nm, according to Mamede et al. Results are shown as 
MFI values51.
Mitochondrial membrane potential measurement. The integrity of the inner mitochondrial 
membrane can be evaluated measuring the potential gradient across this membrane, using the dye 5,5′ ,6,6′ 
-tethrachloro-1,1′ ,3,3′ -tethraethylbenzimidazolcarbocyanine iodide (JC-1). JC-1 is a molecule able to selectively 
enter the cell and exists in 2 forms, aggregates (A) and monomers (M), depending on the polarization/depo-
larization state of mitochondrial membrane. When the mitochondrial membrane potential is high, JC-1 forms 
aggregates that emit red fluorescence (590 nm). In turn, if the mitochondrial membrane potential decreases or 
the membrane is depolarized, JC-1 is excluded from mitochondria and remains in the cytoplasm in the form of 
monomers that emit green fluorescence (529 nm). The ratio between the intensities of green and red fluorescence 
(M/A), determined by flow cytometry, provides a mitochondrial membrane potential estimation51. The results are 
performed by flow cytometry, as previously described13,50,51 and are shown as monomer/aggregate ratio.
Histopathological analysis. For each collected liver fragment, macroscopic description was made accord-
ing to size, external surface and cutting features as colour and consistency. Then the fragments were automatically 
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processed (Shandon Excelsion ES®) and included in paraffin. For microscopic examination, samples were cut at 
3 μ m thickness, processed and stained by haematoxylin and eosin53.
The stained histological sections were evaluated for the presence or absence of tissue damage, hepatocyte 
ballooning, microvesicular steatosis and polymorphonuclear neutrophils aggregates54,55.
Hepatocyte necrosis/apoptosis was estimated based on the number of necrotic foci per field using medium 
magnification (10x objective) and classified in four categories: minimal (< 2 foci); discrete (2–4 foci); moderate 
(5–10 foci) and severe (> 10 foci or “bridging”)56,57.
The mitotic activity was determined by the number of mitosis counted in ten consecutive fields using high 
power magnification (objective 40x/0.57)58.
For the immunohistochemical procedure, the macroscopic recording and processing of the samples were per-
formed within 48 hours after collection, using Novocastra Novolink detection kit (Leica®) according to a protocol 
described by Tsutsumi et al.59.
The immunohistochemical study with Ki-67 antibody allowed a semi-quantitative evaluation of proliferative 
index by determining the percentage of positive hepatocellular nuclei in 1000 hepatocytes60.
Statistical analysis. Statistical analysis was performed using the IBM SPSS® statistical software (version 
21.0). Shapiro–Wilk test was used to evaluate normal distributions for continuous variables. For variables with 
normal distribution parametric tests were used, otherwise the tests used were not parametric. To compare dif-
ferences between Hx and Hx + Asp groups, the Mann-Whitney U-test or the independent samples t-test was 
used. We performed analysis of variance or Kruskal–Wallis test to compare continuous variable time among 
four groups (24, 48, 72 and 120 h). Multiple comparisons were performed considering the Bonferroni correction.
All significance tests were two-tailed and p < 0.05 was considered significant.
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